"The High Cost of Prescription Drugs in the U.S.: A Closer Look"

Drug prices in the United States are nearly double those in other wealthy countries due to a lack of central negotiator, a complicated system of intermediaries, and a dysfunctional healthcare system. Other countries rely on a single negotiating body, usually the government, to decide on drug prices, while the U.S. negotiates with tens of thousands of health plans, resulting in less bargaining power. Additionally, other nations conduct careful analyses of the cost and benefit of new drugs, and are more willing to reject drugs with high costs and minimal benefits.